The Therapeutic Goods Administration (TGA) have issued a product warning for the GLP-1 class of medicines and the potential risk of suicidal thoughts or behaviours.
For more information and the latest updates, see the TGA's medicine safety update for GLP-1 RA class.
The medicine below contain the following active ingredient: semaglutide
You can select a medicine from this list to find out more — including side effects, age restrictions, and whether the medicine is subsidised by the government on the pharmaceutical benefits scheme (PBS).
